| Authors: |
Semple JW; Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden, Clinical Immunology and Transfusion Medicine, Office of Medical Services, Region Skåne, Lund, Sweden; Departments of Pharmacology, Medicine and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, USA. Electronic address: john_w.semple@med.lu.se., Schifferli A; Department of Hematology/Oncology, University Children's Hospital Basel, Basel, Switzerland., Cooper N; Hammersmith Hospital, London, UK., Saad H; Amgen Inc., Thousand Oaks, CA, USA., Mytych DT; Amgen Inc., Thousand Oaks, CA, USA., Chea LS; Amgen Inc., South San Francisco, CA, USA., Newland A; Barts and The London School of Medicine and Dentistry, London, UK. Electronic address: a.c.newland@qmul.ac.uk. |
